Literature DB >> 77033

[The treatment of epileptic encephalopathies with gamma globulin in children (author's transl)].

J C Péchadre, B Sauvezie, C Osier, J Gibert.   

Abstract

PRELIMINARY
RESULTS: The authors have treated 10 children presenting with severe epilepsy with repeated large doses of gamma-globulin. They noted a marked improvement in 7 of the children with respect to behaviour and a disappearance of seizures in 8 with comparable EEG improvement. Four children have been able to reduce their conventional anticonvulsant therapy considerably and 2 others havers received no other medication at all for 8 months. The possibility of an immune disturbance in some childhood epilepsies is thus suggested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 77033     DOI: 10.1016/s0370-4475(77)80049-x

Source DB:  PubMed          Journal:  Rev Electroencephalogr Neurophysiol Clin        ISSN: 0370-4475


  13 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  A risk-benefit assessment of treatments for infantile spasms.

Authors:  R Nabbout
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  High dose intravenous gamma-globulin in intractable epilepsy of childhood.

Authors:  A Etzioni; M Jaffe; S Pollack; N Zelnik; A Benderly; Y Tal
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 4.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

5.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 6.  Immunoglobulin treatment in human and experimental epilepsy.

Authors:  B G van Engelen; W O Renier; C M Weemaes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  Intavenous immunoglobulin for the management of intractable epilepsy in a boy.

Authors:  E Papadopoulou-Alataki; K Garganis; E Dalpa; S Alataki; M Spilioti
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

8.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

Authors:  B G van Engelen; W O Renier; C M Weemaes; P F Strengers; P J Bernsen; S L Notermans
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 9.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.